Skip to main content

Table 2 Parasite burden, treatment data and time of necropsy for the non-treated (NT) and treated (T) subgroups of dogs in Group B

From: Microscopic and molecular analysis of Babesia canis in archived and diagnostic specimens reveal the impact of anti-parasitic treatment and postmortem changes on pathogen detection

No. CBS Postmortem samples Treatment timinga Time of necropsyb
Blood Bone marrow Brain Kidney Liver Lung Lymph node Myocardium Skeletal muscle Spleen
NT-1 na na 27 (L) 492 (VH) 83 (L) 59 (L) 158 (M) na 342 (VH) 0 41 (L) na 36
NT-2 na 36 (L) 324 (VH) 481 (VH) 423 (VH) 163 (M) 319 (VH) 114 (M) 361 (VH) 109 (H) 320 (VH) na 0
NT-3 na 43 (L) 32 (L) 72 (L) 40 (L) 49 (L) 39 (L) 0 57 (L) 0 104 (H) na 36
NT-4 na 29 (L) 17 (L) 84 (L) 58 (L) 52 (L) 60 (L) 0 52 (L) na 39 (L) na 50
NT-5 na 49 (L) 22 (L) 235 (H) 202 (H) 68 (L) 79 (L) 54 (L) 226 (H) 159 (H) 137 (H) na 48
NT-6 159 (M) 125 (M) 347 (VH) 286 (H) 320 (VH) 157 (H) 82 (L) 24 (L) na 123 (H) 109 (H) na 40
T-1 81 (L) 29 (L) 207 (H) 161 (M) 207 (H) 139 (M) 41 (L) 217 (H) 232 (H) 205 (H) 184 (M) 6 17
T-2 138 (M) 25 (L) 322 (VH) 478 (VH) 413 (VH) 193 (M) 90 (L) 56 (L) 361 (VH) 0 309 (H) 6 21
T-3 94 (L) 47 (L) 21 (L) 312 (VH) 92 (L) 83 (L) 118 (M) 34 (L) 134 (M) 48 (L) 57 (L) 10 2
T-4 na 0 0 0 0 0 0 0 0 0 0 10 6
T-5 164 (M) 103 (M) 0 0 0 0 8 (L) 0 0 0 0 24 0
T-6 51 (L) 0 0 0 0 0 0 0 0 0 0 24 11
T-7 47 (L) 0 0 0 0 0 0 0 0 na 0 24 1
T-8 na 0 0 0 0 0 0 0 0 na 0 24 3
T-9 73 (L) 0 0 0 0 0 0 0 0 na 0 48 20
  1. aHours before death
  2. bHours after death. Infection with B. canis was confirmed by PCR in organ samples from all dogs
  3. Abbreviations: No., dog number; CBS, clinical blood smears made from the cephalic vein blood of clinical patients; na, not applicable; L, low parasite burden; M, moderate parasite burden; H, high parasite burden; VH, very high parasite burden